GB1539364A - 11-deoxy-11-oxaprostaglandin compounds - Google Patents

11-deoxy-11-oxaprostaglandin compounds

Info

Publication number
GB1539364A
GB1539364A GB38389/77A GB3838977A GB1539364A GB 1539364 A GB1539364 A GB 1539364A GB 38389/77 A GB38389/77 A GB 38389/77A GB 3838977 A GB3838977 A GB 3838977A GB 1539364 A GB1539364 A GB 1539364A
Authority
GB
United Kingdom
Prior art keywords
oxaprostaglandin
deoxy
compounds
oxaprostaglandin compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38389/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of GB1539364A publication Critical patent/GB1539364A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Manipulator (AREA)
GB38389/77A 1976-09-15 1977-09-14 11-deoxy-11-oxaprostaglandin compounds Expired GB1539364A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72360476A 1976-09-15 1976-09-15

Publications (1)

Publication Number Publication Date
GB1539364A true GB1539364A (en) 1979-01-31

Family

ID=24906946

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38389/77A Expired GB1539364A (en) 1976-09-15 1977-09-14 11-deoxy-11-oxaprostaglandin compounds

Country Status (9)

Country Link
JP (1) JPS5337653A (enrdf_load_stackoverflow)
BE (1) BE858682A (enrdf_load_stackoverflow)
DE (1) DE2739277C2 (enrdf_load_stackoverflow)
DK (1) DK408377A (enrdf_load_stackoverflow)
FR (1) FR2364912A1 (enrdf_load_stackoverflow)
GB (1) GB1539364A (enrdf_load_stackoverflow)
IE (1) IE45773B1 (enrdf_load_stackoverflow)
LU (1) LU78116A1 (enrdf_load_stackoverflow)
NL (1) NL169739C (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
WO1998057930A1 (en) * 1997-06-18 1998-12-23 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5994397A (en) * 1995-12-22 1999-11-30 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
JPS5915198A (ja) * 1982-07-15 1984-01-26 石川島播磨重工業株式会社 シ−ルド掘進機
JPS5927846U (ja) * 1982-08-13 1984-02-21 日本ワグナ−・スプレ−テツク株式会社 空圧制御式スプレ−ガン
JPS59210190A (ja) * 1983-05-11 1984-11-28 大和技建株式会社 圧気シ−ルド推進工法

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5994397A (en) * 1995-12-22 1999-11-30 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US6025392A (en) * 1995-12-22 2000-02-15 Alcon Laboratories, Inc. substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US6197812B1 (en) 1995-12-22 2001-03-06 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US6369102B2 (en) 1995-12-22 2002-04-09 Alcon Manufacturing, Ltd. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
WO1998057930A1 (en) * 1997-06-18 1998-12-23 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives

Also Published As

Publication number Publication date
FR2364912B1 (enrdf_load_stackoverflow) 1980-10-03
IE45773B1 (en) 1982-11-17
LU78116A1 (fr) 1979-05-23
NL7710065A (nl) 1978-03-17
NL169739B (nl) 1982-03-16
JPS5755719B2 (enrdf_load_stackoverflow) 1982-11-25
DK408377A (da) 1978-03-16
NL169739C (nl) 1982-08-16
IE45773L (en) 1978-03-15
BE858682A (fr) 1978-03-14
JPS5337653A (en) 1978-04-06
DE2739277A1 (de) 1978-03-16
FR2364912A1 (fr) 1978-04-14
DE2739277C2 (de) 1982-06-09

Similar Documents

Publication Publication Date Title
IL48824A0 (en) Thc-type compounds
JPS5368786A (en) Heterocycltc compound
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5297994A (en) Betaalactummcontaining compounds
JPS5317639A (en) Hexakisazo compounds
JPS5359686A (en) Compound
JPS5295689A (en) Betaalactummcontaining compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5325537A (en) Compound
CY1178A (en) 21-halogenopregnane compounds
JPS5293772A (en) Indolinospiropyran compound
JPS5323995A (en) Antiibacterial compound
GB1539364A (en) 11-deoxy-11-oxaprostaglandin compounds
JPS52156899A (en) Compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52111590A (en) Novel cephalospoline compounds
JPS5353692A (en) Antiiworm compound
JPS52102227A (en) Haloalkylphosphate compounds
ZA772175B (en) Oxothia compounds
JPS5285216A (en) Azamethineemetal complex compounds
JPS5353693A (en) Antiiworm compound
JPS52125158A (en) Oxothia compound
JPS5297990A (en) Cephalospoline compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee